Ariz. Admin. Code § R9-6-386 - Smallpox
A. Case
control measures:
1. A diagnosing health care
provider or an administrator of a health care institution, either personally or
through a representative, shall isolate and institute both airborne precautions
and contact precautions for a smallpox case or suspect case, until evaluated
and determined to be noninfectious by a physician, physician assistant, or
registered nurse practitioner.
2. A
local health agency shall: 1.a. Upon receiving a
report under
R9-6-202
of a smallpox case or suspect case, notify the Department within 24 hours after
receiving the report and provide to the Department the information contained in
the report;
2.b. In consultation with
the Department: a.i. Ensure that isolation
and both airborne precautions and contact precautions have been instituted for
a smallpox case or suspect case to prevent transmission, and
b.ii.
Conduct an epidemiologic investigation of each reported smallpox case or
suspect case;
3.c. For each smallpox
case, submit to the Department, as specified in Table 2.4, the information
required under
R9-6-206(D);
and
d. In consultation with the
Department, ensure that a specimen from each smallpox case or suspect case, as
required by the Department, is submitted to the Arizona State
Laboratory.
B.
Contact control measures: A local health agency, in consultation with the
Department, shall:
1. Quarantine or exclude a
smallpox contact as necessary, according to
R9-6-303,
to prevent transmission; and
2.
Monitor the contact for smallpox symptoms, including fever, each day for 21
calendar days after last exposure.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
A. Case control measures:
1. A diagnosing health care provider or an administrator of a health care institution, either personally or through a representative, shall isolate and institute airborne precautions for: d. c. A case or suspect case of multi-drug resistant active tuberculosis until a tuberculosis control officer has approved the release of the case or suspect case.
a. An individual with infectious active tuberculosis until: b.ii. Anti-tuberculosis treatment is initiated with multiple antibiotics; and c.iii. Clinical signs and symptoms of active tuberculosis are improved;
i. At least three successive sputum smears collected at least eight hours apart, at least one of which is taken first thing in the morning as soon as possible after the individual awakens from sleep, are negative for acid-fast bacilli;
b. A suspect case of infectious active tuberculosis until:
i. At least two successive tests for tuberculosis, using a product and methodology approved by the U.S. Food and Drug Administration for use when making decisions whether to discontinue isolation and airborne precautions, for the suspect case are negative; or
ii. At least three successive sputum smears collected from the suspect case as specified in subsection (A)(1)(a)(i) are negative for acid-fast bacilli, anti-tuberculosis treatment of the suspect case is initiated with multiple antibiotics, and clinical signs and symptoms of active tuberculosis are improved; and
2. An administrator of a health care institution, either personally or through a representative, shall notify a local health agency at least one working day before discharging a tuberculosis case or suspect case.
3. A local health agency shall:a.b. Exclude an individual with infectious active tuberculosis or a suspect case from working, unless the individual's work setting has been approved by a tuberculosis control officer, until the individual with infectious active tuberculosis or suspect case is released from airborne precautions according to the applicable criteria in subsection (A)(1); b.c. Conduct an epidemiologic investigation of each reported tuberculosis case, suspect case, or latent infection in a child five years of age or younger; c.d. For each tuberculosis case or suspect case, submit to the Department, as specified in Table 2.4, the information required under R9-6-206(D); d.e. Ensure that an isolate or a specimen, as available, from each tuberculosis case is submitted to the Arizona State Laboratory; and
a. Upon receiving a report under R9-6-202 of a tuberculosis case or suspect case, notify the Department within one working day after receiving the report and provide to the Department the information contained in the report;
i. At least three successive sputum smears collected at least eight hours a part, at least one of which is taken first thing in the morning as soon as possible after the individual awakens from sleep, are negative for acid-fast bacilli;
ii. Anti-tuberculosis treatment is initiated with multiple antibiotics;
iii. Clinical signs and symptoms of active tuberculosis are improved; and
iv. For a case of multi-drug resistant active tuberculosis, a tuberculos is control officer has approved the release of the case from airborne precautions
B. Contact control measures:
1. A contact of an individual with infectious active tuberculosis shall allow a local health agency to evaluate the contact's tuberculosis status.
2. A local health agency shall comply with the tuberculosis contact control measures specified in R9-6-1202.
C. An individual is not a tuberculosis case if the individual has a positive result from an approved test for tuberculosis but does not have clinical signs or symptoms of disease.